Blog

The Medical Minute: Irregular periods, weight gain and facial hair? It could be PCOS - Penn State Health News

When Dr. Sushrutha Sridhar, an endocrinology, diabetes and metabolism fellow at Penn State College of Medicine, began no

Postpartum hemorrhage linked to increased cardiovascular problems years later

Oksana Sirenko Discover how 3D biology, automation, and AI are revolutionizing drug discovery, improving predictive accu

Why Low Cost Weight Loss Drugs Are Disappearing

People searching for lower-priced GLP-1 weight loss drugs are facing a series of obstacles lately. On Monday, a pharmace

The Fungus Blamed For “Tutankhamun’s Curse” Could Make A Potent Anti-Cancer Drug | IFLScience

The fungus Aspergillus flavus produces a class of molecules that have strong potential as future anti-leukemia drugs, al

ACM Awards 2025: See the Complete Winners List!

The 2025 Academy of Country Music Awards, hosted by Reba McEntire, air live from Ford Center at the Star in Frisco, Texa

1. 7 million patients reveal stunning link between semaglutide and lower dementia risk | ScienceDaily

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-lo

California man arrested in Levy County narcotic theft investigation

BRONSON, Fla. (WCJB) - Deputies with the Levy County Sheriff’s Office (LCSO) said they’ve arrested a man in an investiga

Should CV Risk Equations Add Lp(a)?

Whether to measure Lp(a), a lipoprotein associated with increased cardiovascular risk, and how to use that information i

Popular weight-loss drug shows promise in reducing dementia risk for seniors with diabetes, major study finds - McKnight's Long-Term Care News

A new study involving nearly 1.7 million patients suggests that semaglutide — a drug that mimics a gut hormone to lower

Heisman Trophy winners, runners-up since 1935 | NCAA.com

Here is a complete list of every Heisman Trophy winner since 1935 and the players that finished second and third each se

Ascidian Therapeutics Appoints Dr. Murray A. Abramson as Chief Development Officer and Establishes Ophthalmology Clinical Advisory Board to Advance ACDN-01 for Treatment of Stargardt Disease

Jun 24, 2025, 07:00 ET Share this article BOSTON, June 24, 2025 /PRNewswire/ -- Ascidian Therapeutics, a biotechnology c

IDH status dictates oHSV mediated metabolic reprogramming affecting anti-tumor immunity | Nature Communications

Nature Communications volume 16, Article number: 3874 (2025) Cite this article 2974 Accesses Metrics details Identificat